Dr. Lipo + V is a Korean facial lipolytic that pairs phosphatidylcholine (PPC) and deoxycholate with EGF and peptides, positioned for a “V-line” effect. The manufacturer aims it at facial fat and the jawline. Injectable fat dissolving is a medical procedure for a licensed professional, never a do-it-yourself step.
What is in Dr. Lipo + V?
Dr. Lipo + V is a face-targeted lipolytic, packed as 5 ml vials. Its base pairing is phosphatidylcholine (PPC), a fat-emulsifying compound, with deoxycholate (DC), a bile salt. To that the maker adds EGF (epidermal growth factor) and two peptides, acetyl hexapeptide-8 and palmitoyl pentapeptide-4, which it positions as skin-firming and regenerative.
The manufacturer’s pitch is a “double effect”: fat reduction plus skin tightening for the jawline, cheeks, and submental area. Those are positioning claims, not regulatory findings. For the body-targeted sibling using the same PPC base, see Dr. Lipo (Blue Box).
Log Notes. This page explains what Dr. Lipo + V is and how its maker describes it. It gives no volumes, depths, point spacing, session counts, mixing steps, or technique. Those belong to a licensed professional, not a blog. Nothing here is medical advice, and injectable fat dissolving is never a do-it-yourself procedure.
How is a facial lipolytic different?
The face is unforgiving territory for injections. Published reviews describe PPC as emulsifying fat and deoxycholate as disrupting the fat-cell membrane (PMC review of injection lipolysis). The added growth factor and peptides are marketed for collagen support, but a mechanism on paper is not proof of a safe facial outcome.
Facial anatomy packs nerves and vessels into a small area, which is exactly why candidacy and technique belong with a professional. If you are weighing the jawline against a muscle-relaxant approach for a sharper lower face, that is a different conversation, see Botox on jaw.
Is Dr. Lipo + V FDA-approved?
No. The only injectable the U.S. Food and Drug Administration has approved for dissolving fat is deoxycholic acid (Kybella), and only for fat under the chin (submental fat). Cheek, jawline, and nasolabial fat are not on that label, and growth-factor lipolytics like Dr. Lipo + V are generally not FDA-approved.
The FDA has warned directly that fat-dissolving injections that are not FDA-approved can be harmful (FDA, fat-dissolving injections). On the face, the margin for error is small, and any injectable lipolysis is a clinical procedure for a licensed professional, never a DIY attempt.
What is worth tracking?
A gradual course and a steady record. Facial lipolytics act over weeks, so the comparison that matters is month over month, and reactions like swelling and tenderness near the jaw are commonly reported. Faces change subtly, which makes a dated photo log especially useful.
That is the role Dosefi can play. You log each session with its date and a photo, set a reminder for the review window your provider gives you, and watch the treated area over the following weeks so a real timeline replaces guesswork. A log never makes a procedure safe. It keeps your own history organized for the conversations that matter.
A grounded takeaway
Dr. Lipo + V is a facial PPC-and-deoxycholate lipolytic with EGF and peptides, positioned for a V-line effect. The honest headline is regulatory: only submental deoxycholic acid is FDA-approved, and the FDA warns non-approved fat-dissolving injections can be harmful. On the face, that caution carries extra weight. This is a medical decision for a licensed professional, never a DIY route.
Sources
- “Using Fat-Dissolving Injections (Are Not FDA-Approved, Can Be Harmful)” (FDA). Regulatory caution that non-approved fat-dissolving injections can cause harm.
- “Injection lipolysis review” (PMC). Background on how PPC and deoxycholate are described in the literature.
